HARPOON THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Harpoon Therapeutics, Inc. - HARPBusiness Wire • 01/10/24
Shareholder Alert: Ademi LLP investigates whether Harpoon Therapeutics, Inc. has obtained a Fair Price in its transaction with MerckPRNewsWire • 01/08/24
HARP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Harpoon Therapeutics, Inc. Is Fair to ShareholdersBusiness Wire • 01/08/24
Merck to Acquire Harpoon Therapeutics, Further Diversifying Oncology PipelineBusiness Wire • 01/08/24
Harpoon Therapeutics Abstract for HPN328 Accepted for Rapid Oral Presentation at the 2024 American Society of Clinical Oncology Genitourinary Cancers SymposiumGlobeNewsWire • 12/19/23
Harpoon Therapeutics Presents HPN217 Phase 1 Clinical Data in Relapsed/Refractory Multiple Myeloma (RRMM) at ASH 2023 and Announces Selection of Recommended Phase 2 Dose (RP2D)GlobeNewsWire • 12/12/23
5 Small Drug Stocks to Buy on Hopes of Better Prospects in the New YearZacks Investment Research • 12/11/23
Should You Buy Harpoon Therapeutics, Inc. (HARP) After Golden Cross?Zacks Investment Research • 12/11/23
Harpoon Therapeutics, Inc. (HARP) Upgraded to Strong Buy: What Does It Mean for the Stock?Zacks Investment Research • 12/05/23
Wall Street Analysts Believe Harpoon Therapeutics, Inc. (HARP) Could Rally 40.5%: Here's is How to TradeZacks Investment Research • 11/30/23
Fast-paced Momentum Stock Harpoon Therapeutics, Inc. (HARP) Is Still Trading at a BargainZacks Investment Research • 11/15/23
Wall Street Analysts See a 92.31% Upside in Harpoon Therapeutics, Inc. (HARP): Can the Stock Really Move This High?Zacks Investment Research • 11/14/23
Harpoon Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateGlobeNewsWire • 11/09/23
Harpoon Therapeutics Abstract for HPN217 Accepted for Presentation at the 65th American Society of Hematology (ASH) Annual Meeting and ExpositionGlobeNewsWire • 11/02/23